🔥KI Reports is excited to report our 2021 impact factor of 6.234!
We would like to thank our readers, authors, editors and reviewers! We could not continue to grow and improve without your continued support
PRAKI in South Asia remains a race against limited resources. 🤰🏽🩺
🧬 Genetic testing is rarely performed
💊 Eculizumab is unavailable or inaccessible for most pts
🩸 Even plasmapheresis is not universally available
Check out our article from KIR. 🚨🌏 #PrAKI#KidneyHealth #SouthAsia #HealthEquity
Source: Kidney International Reports https://t.co/WSuzVVNhUa
ISN membership connects you to the latest in kidney science, helping you grow professionally and stay at the forefront of nephrology through valuable resources, opportunities, and a global community committed to advancing kidney care.
📖 This weekend’s @KIReports #ISNFridaySelection is open access: Prospective Study of Multiparametric Renal MRI for CKD Progression (AFiRM) ➡️ https://t.co/cLgovZYJWJ
Grow with the ISN. Join or renew your membership and access all ISN journals ➡️ https://t.co/lEI9kBWCY0
#ThisIsISN – Advancing kidney health worldwide. Together.
🚨#Tweetorial alert🚨- brought to you by @KIReports@ISNkidneycare#NephTwitter
Not all preeclampsia (PE) is the same. New data on isolated PE vs PE-HELLP syndrome—and why close monitoring matters for patients' cardiovascular and kidney health
https://t.co/WNpxQeDJEg